Analysis of TCGA–ACC dataset revealed that the KRT17 mutation status of ACC was associated with OS, DSS, and PFS, In ESCA, STAD, and UCEC, a correlation was not found, indicating that tumor development and clinical outcomes are not simply influenced by mutation status but rather by a complex genetic process. This evidence concerns the gene KRT17 and adrenal cortex carcinoma.